Novel biomarker for pulmonary fibrotic sarcoidosis

Novel biomarker for pulmonary fibrotic sarcoidosis - Biomarker for pulmonary sarcoidosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220381

Enrollment

Registered

2018-09-07

Start date

2017-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcoidosis

Interventions

Intervention type:PROCEDURE Name of intervention:Sample collection by healthy volunteers Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application:NOT APPLICABLE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Sarcoidosis patients with written informed consent

Exclusion criteria

Exclusion criteria: Patients with collagen vascular disease, allergic disease, malignant tumors were excluded

Design outcomes

Primary

Measure	Time frame
Correlation between plasma concentration of biomarkers and clinical background	—

Countries

Japan

Contacts

Public ContactTakuma Isshiki

Toho university

takuma.isshiki@med.toho-u.ac.jp+81-3-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026